Intellipharmaceutics International Inc. (IPCI)

[Digdeeper1976]

Samsa and I go way back to the yahoo days. She knows my the dig deeper board name. My argument over 2 years ago was, odidi was incompetent as a CEO. Rexista would never be approved without a phase 3. Regablin would never be approved and most of the generic pipeline was garbage. Now these arguments are proven correct.

The "company" has very little revenue, virtually no pipeline, dwindling cash and a huge time and money expense with a phase 3.

People should readthe article at the top of this board
Analysts Weigh in on IntelliPharmaCeutics International Inc. (IPCI) as Rexista NDA Pathway Shortened
May 22, 2015

“We estimate that the freedom to forego Phase 3 testing will shave off at least $20 million from the cost of development, as well as about 18-24 months of time.

Investors have 2 years of phase 3 clinical trials and another 20 million of dilution to look forward to.
Based on the outlook for this "company" I am surprised it is still trading over $1.